West Pharmaceutical Services to Present at Key Investor Conferences in September

  • West Pharmaceutical Services (NYSE: WST) will present at the Wells Fargo Annual Healthcare Conference on September 10, 2026, in Everett, MA.
  • The company will also present at the Morgan Stanley Annual Global Healthcare Conference on September 14, 2026, in New York, NY.
  • Live webcasts of the presentations will be available on West's Investors section, with replays accessible for 90 days post-event.
  • West generated $3.07 billion in net sales in fiscal year 2025, with over 10,000 employees across 50 sites globally.

West Pharmaceutical Services' participation in these high-profile investor conferences underscores its strategic focus on engaging with key stakeholders to discuss its market position and financial performance. As a trusted partner to drug developers, West's presentations will likely highlight its innovative solutions and global manufacturing capabilities, which are critical in the rapidly evolving healthcare sector. The company's inclusion in the S&P 500 further emphasizes its significance in the industry.

Market Positioning
How West's presentations will emphasize its role as a global leader in injectable drug administration solutions.
Financial Performance
Whether the company will provide updates on its fiscal year 2026 outlook and growth strategies.
Industry Trends
The pace at which West is adapting to evolving healthcare and pharmaceutical industry dynamics.